Novartis Urges Court To Make FDA Block Entresto Generic

By Andrew Karpan · March 21, 2025, 8:48 PM EDT

Novartis says the U.S. Food & Drug Administration has made a drug marketing exclusivity window "meaningless" and wants a D.C. federal judge to block a rival from selling a generic drug...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

NOVARTIS PHARMACEUTICALS CORPORATION v. BECERRA et al

Case Number

Court

District Of Columbia

Nature of Suit

Other Statutory Actions

Date Filed

January 13, 2025

Recent Articles By Andrew

March 28, 2025
Doctor's Counterclaims Cut In 'Groq' TM Feud With Chipmaker
March 18, 2025
ITC To Review Whether Tourniquet Importers Are Ignoring Ban
March 17, 2025
New Bills Target 'Patent Thickets' And 'Product Hopping'
February 24, 2025
Patent Eligibility Appeals 'Will Not Go Away,' Justices Told
February 12, 2025
Labcorp Can't Score New Trial After $384M Patent Loss
February 06, 2025
Drug Cos. Urge Full Fed. Circ. To Hear Teva Orange Book Row
January 08, 2025
Patent Board Knocks Out Most Of Apple Patent
January 08, 2025
Telligen's TM Suit Against IT Co. Can Move Forward
January 06, 2025
Labcorp Loses Appeal Of Gene-Testing Patent In $372M Case
December 04, 2024
Withers IP Partners Hop To Sullivan & Worcester